VAVRICKA JOHN

PrivateCIK: 1829630

VAVRICKA JOHN (Chief Commercial Officer) received a stock award from ATEA PHARMACEUTICALS, INC.

Compensation award — not an open‑market transaction. Less informative as a directional signal.

A · 1 award
InsiderVAVRICKA JOHNCIK 1829630
Officer· Chief Commercial Officer
Since Oct 2020
+138.78K
Net shares
Net buyer
$35.2K
Total sold
0
Open market trades
0B · 0S
6
Total transactions
183.63K acquired · 44.85K disposed
Non-Derivative Transactions3

Common Stock

Direct
M · Option Exercise

Shares

+33.33K

Price / share

Trade value

% of position

154.9%
1/31/2025
21.52K54.85K

Common Stock

Direct
A · Award

Shares

+8.75K

Price / share

Trade value

% of position

16.0%
1/31/2025
54.85K63.60K

Common Stock

Direct
F · Tax Withholding

Shares

11.52K

Price / share

$3.06

Trade value

$35.24K

% of position

18.1%
1/31/2025
63.60K52.08K
Total

Net shares

+30.57K

Net value

-$35.24K

Derivative Transactions3

Restricted Stock Units

Direct
M · Option Exercise
Converts to

Common Stock

33.33K shares

Shares

33.33K

Strike price

Held after

33.33K

Exercisable

1/31/2025

Restricted Stock Units

Direct
A · Award
Converts to

Common Stock

8.75K shares

Shares

+8.75K

Strike price

Held after

8.75K

Exercisable

1/31/2025

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Common Stock

132.80K shares

Shares

+132.80K

Strike price

3.06

Held after

132.80K

Exercisable

1/31/2025
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned82.51K
Total
82.51K indirect82.51K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
VAVRICKA JOHN — Insider Transaction (Form 4) Filed Feb 4, 2025 | Finecho